Article
Intra-tumoral heterogeneity and immune responses predicts prognosis of gastric cancer.
Aging - 26 Nov 2020
Feng Wanjing, Wang Yue, Chen Siyuan, Zhu Xiaodong
Abstract excerpt
Chemotherapy resistance eventually develops in patients with gastric cancer (GC). Intra-tumoral heterogeneity (ITH) refers to the intercellular genetic variations and phenotypic diversity that affect responses to drug therapy. We measured ITH using mutant-allele tumor heterogeneity (MATH) derived from whole-exome sequencing data of patients with GC in The Cancer Genome Atlas (TCGA) database. The study included...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
